Business
Starpharma (ASX:SPL) share price dips on quarterly update // The Motley Fool Australia
The Starpharma Holdings Limited (ASX: SPL) share price has dipped slightly today after the company released its quarterly cashflow and activities report for the quarter ended 31 December 2020.
Starpharma is a global biopharmaceutical company that develops pharmaceutical and medical products based on proprietary polymers called dendrimers. Dendrimers are man-made nanoscale compounds that can be used both to enhance existing health products and as entirely new products.
The company is presently developing Viraleze, an antiviral nasal spray for COVID-19 that is complementary to vaccines and other preventative measures.
Here are some highlights from the company’s quarterly update.
Starpharma developments during the December…
-
General9 hours agoOverheated share markets may risk financial meltdown
-
Business11 hours agoWhere will the CBA share price go next? Here’s what the experts say
-
Business9 hours agoMacquarie tips 60%+ return for this ASX All Ords stock
-
Business12 hours agoWhy Morgans upgraded TPG, ANZ Bank, and this ASX share